ARWR - Arrowhead Pharmaceuticals GAAP EPS of -$0.96 misses by $0.37 revenue of $15.83M misses by $29.59M
2023-08-07 16:40:39 ET
- Arrowhead Pharmaceuticals press release ( NASDAQ: ARWR ): Q3 GAAP EPS of -$0.96 misses by $0.37 .
- Revenue of $15.83M (-51.2% Y/Y) misses by $29.59M .
For further details see:
Arrowhead Pharmaceuticals GAAP EPS of -$0.96 misses by $0.37, revenue of $15.83M misses by $29.59M